AMICUS THERAPEUTICS, INC. — Director's Dealing 2015

Jul 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-07-16

Reporting Person: Crowley John F (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-16	Common Stock	M	16025	$16.00	Acquired	99524	Direct
2015-07-16	Common Stock	S	16025	$16.00	Disposed	83499	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-16	Stock Options (right to buy)	$5.96	M	16025	Disposed	2021-01-19	Common Stock (16025)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	64895	Indirect

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.